INVESTIGATIONAL PRODUCTS. Parties acknowledge and agree that the Institution’s pharmacy, or such other pharmacy as appointed by Sponsor the Principal Investigator and the Institution, will be responsible for certain tasks in relation with the handling of the Investigational Product. Any agreements between the pharmacy and any of the Parties will be in writing and must be in accordance with the Institution’s internal policies. Any such agreements will be annexed to this Agreement as applicable. Subject to the foregoing, the Sponsor and/or CRO will provide the Principal Investigator and the pharmacy with all necessary information on the Investigational Product(s), quality and handling instructions thereof and sufficient quantities needed to conduct the Clinical Trial free of charge. The Site Parties shall not use or permit the Research Staff or any third party to use the Investigational Product for any purpose other than the conduct of the Clinical Trial and upon termination or expiration of this Agreement all unused Investigational Product shall, at the Sponsor’s option, either be returned to the Sponsor or disposed of in accordance with the Protocol or the Sponsor’s written instructions.
Appears in 4 contracts
Samples: Clinical Trial Agreement, Clinical Trial Agreement, Clinical Trial Agreement
INVESTIGATIONAL PRODUCTS. 7.1. Parties acknowledge and agree that the Institution’s pharmacy, or such other pharmacy as appointed by Sponsor the Principal Investigator and the Institution, will be responsible for certain tasks in relation with the handling of the Investigational Product. Any agreements between the pharmacy and any of the Parties will be in writing and must be in accordance with the Institution’s internal policies. Any such agreements will be annexed to this Agreement as applicable.
7.2. Subject to the foregoing, the Sponsor and/or CRO will provide the Principal Investigator and the pharmacy with all necessary information on the Investigational Product(s), quality and handling instructions thereof and sufficient quantities needed to conduct the Clinical Trial free of charge.
7.3. The Site Parties shall not use or permit the Research Staff or any third party to use the Investigational Product for any purpose other than the conduct of the Clinical Trial and upon termination or expiration of this Agreement all unused Investigational Product shall, at the Sponsor’s option, either be returned to the Sponsor or disposed of in accordance with the Protocol or the Sponsor’s written instructions.
Appears in 2 contracts
INVESTIGATIONAL PRODUCTS. Parties acknowledge and agree that the Institution’s pharmacy, or such other pharmacy as appointed by Sponsor Xxxxxxx, the Principal Investigator and the Institution, will be responsible for certain tasks in relation with to the handling of the Investigational Product. Any agreements between the pharmacy and any of the Parties will be in writing and must be in accordance with the Institution’s internal policies. Any such agreements will be annexed to this Agreement as Annex 4, if applicable. Subject to the foregoing, the Sponsor and/or CRO will provide the Principal Investigator and the pharmacy with all necessary information on the Investigational Product(s), quality and handling instructions thereof and sufficient quantities needed to conduct the Clinical Trial free of charge. The Site Parties shall not use or permit the Research Staff or any third party to use the Investigational Product for any purpose other than the conduct of the Clinical Trial and upon termination or expiration of this Agreement all unused Investigational Product shall, at the Sponsor’s option, either be returned to the Sponsor or disposed of in accordance with the Protocol or the Sponsor’s written instructions.
Appears in 1 contract
Samples: Clinical Trial Agreement
INVESTIGATIONAL PRODUCTS. Parties acknowledge and agree that the Institution’s pharmacy, or such other pharmacy as appointed by Sponsor Sponsor, the Principal Investigator and the Institution, will be responsible for certain tasks in relation with to the handling of the Investigational Product. Any agreements between the pharmacy and any of the Parties will be in writing and must be in accordance with the Institution’s internal policies. Any such agreements will be annexed to this Agreement as Annex 4, if applicable. Subject to the foregoing, the Sponsor and/or CRO will provide the Principal Investigator and the pharmacy with all necessary information on the Investigational Product(s), quality and handling instructions thereof and sufficient quantities needed to conduct the Clinical Trial free of charge. The Site Parties shall not use or permit the Research Staff or any third party to use the Investigational Product for any purpose other than the conduct of the Clinical Trial and upon termination or expiration of this Agreement all unused Investigational Product shall, at the Sponsor’s option, either be returned to the Sponsor or disposed of in accordance with the Protocol or the Sponsor’s written instructions.
Appears in 1 contract
Samples: Clinical Trial Agreement
INVESTIGATIONAL PRODUCTS. Parties acknowledge and agree that the Institution’s pharmacy, or such other pharmacy as appointed by Sponsor Sponsor, the Principal Investigator and the Institution, will be responsible for certain tasks in relation with the handling of the Investigational Product. Any agreements between the pharmacy and any of the Parties will be in writing and must be in accordance with the Institution’s internal policies. Any such agreements will be annexed to this Agreement as applicable. Subject to the foregoing, the Sponsor and/or CRO will provide the Principal Investigator and the pharmacy with all necessary information on the Investigational Product(s), quality and handling instructions thereof and sufficient quantities needed to conduct the Clinical Trial free of charge. The Site Parties shall not use or permit the Research Staff or any third party to use the Investigational Product for any purpose other than the conduct of the Clinical Trial and upon termination or expiration of this Agreement all unused Investigational Product shall, at the Sponsor’s option, either be returned to the Sponsor or disposed of in accordance with the Protocol or the Sponsor’s written instructions.
Appears in 1 contract
Samples: Clinical Trial Agreement